-
-
-
WuXi AppTec's Q1 2025 Financial report
Market Trend
WuXi AppTec reports strong Q1 2025 results with net profit up 89% YoY and orders reaching RMB 52.33 billion. Its CRDMO model drives growth across chemistry, testing, and biology services, showing resilience amid global challenges.
-
WuXi AppTec API Facilities Pass FDA Inspection
WuXi AppTec
WuXi AppTec's Changzhou and Taixing API sites successfully passed FDA inspections in March with zero deficiencies. The sites, key to WuXi TIDES and STA Pharmaceutical, ensure compliance for complex molecule synthesis and commercial production.
-
-
-
-
-
安化县|
阳江市|
呼和浩特市|
大英县|
蕲春县|
彰武县|
且末县|
娄底市|
克什克腾旗|
麟游县|
永丰县|
博乐市|
南安市|
永登县|
宁波市|
武威市|
泗洪县|
余庆县|
汾西县|
怀化市|
宁蒗|
舒城县|
宜君县|
集贤县|
江油市|
秦皇岛市|
连平县|
祁连县|
南和县|
胶州市|
桂林市|
敦煌市|
磴口县|
闽清县|
洪湖市|
陆河县|
西吉县|
托克逊县|
云霄县|
桐柏县|
洞口县|